Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Garmo

Showing results (231-240 of 261) with videos related to

Pageof 27
Sort By:
JAMA Network Open|November 7, 2019
Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy ResultsKerri Beckmann, Danielle Crawley, Tobias Nordström, et al.
International Journal of Cancer|November 13, 2020
Risk of cardiovascular disease following gonadotropin-releasing hormone agonists vs antagonists in prostate cancer: Real-world evidence from five databasesGincy George, Hans Garmo, Lucie-Marie Scailteux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2014
Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS TrialFredrik Wärnberg, Hans Garmo, Stefan Emdin, et al.
BMJ Open|October 1, 2017
Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe)Christel Häggström, Fredrik Liedberg, Oskar Hagberg, et al.
British Journal of Cancer|December 15, 2015
Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval timeJennifer C Melvin, Arnie D Purushotham, Hans Garmo, et al.
International Journal of Epidemiology|May 8, 2012
Cohort Profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0Mieke Van Hemelrijck, Annette Wigertz, Fredrik Sandin, et al.
Oncoimmunology|July 30, 2016
Investigating the association between allergen-specific immunoglobulin E, cancer risk and survivalWahyu Wulaningsih, Lars Holmberg, Hans Garmo, et al.
JNCI Cancer Spectrum|May 7, 2020
Comparative Effectiveness of Different Radical Radiotherapy Treatment Regimens for Prostate Cancer: A Population-Based Cohort StudyAndreas Pettersson, Daniel Alm, Hans Garmo, et al.
International Journal of Molecular Sciences|September 9, 2016
Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective StudiesWahyu Wulaningsih, Harkiran K Sagoo, Mustafa Hamza, et al.
BMC Cancer|November 19, 2015
Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysisWahyu Wulaningsih, Mariam Vahdaninia, Mark Rowley, et al.
Pageof 27

Showing results (231-240 of 261) with videos related to

Sort By:
Pageof 27
JAMA Network Open|November 7, 2019
Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy ResultsKerri Beckmann, Danielle Crawley, Tobias Nordström, et al.
International Journal of Cancer|November 13, 2020
Risk of cardiovascular disease following gonadotropin-releasing hormone agonists vs antagonists in prostate cancer: Real-world evidence from five databasesGincy George, Hans Garmo, Lucie-Marie Scailteux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2014
Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS TrialFredrik Wärnberg, Hans Garmo, Stefan Emdin, et al.
BMJ Open|October 1, 2017
Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe)Christel Häggström, Fredrik Liedberg, Oskar Hagberg, et al.
British Journal of Cancer|December 15, 2015
Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval timeJennifer C Melvin, Arnie D Purushotham, Hans Garmo, et al.
International Journal of Epidemiology|May 8, 2012
Cohort Profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0Mieke Van Hemelrijck, Annette Wigertz, Fredrik Sandin, et al.
Oncoimmunology|July 30, 2016
Investigating the association between allergen-specific immunoglobulin E, cancer risk and survivalWahyu Wulaningsih, Lars Holmberg, Hans Garmo, et al.
JNCI Cancer Spectrum|May 7, 2020
Comparative Effectiveness of Different Radical Radiotherapy Treatment Regimens for Prostate Cancer: A Population-Based Cohort StudyAndreas Pettersson, Daniel Alm, Hans Garmo, et al.
International Journal of Molecular Sciences|September 9, 2016
Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective StudiesWahyu Wulaningsih, Harkiran K Sagoo, Mustafa Hamza, et al.
BMC Cancer|November 19, 2015
Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysisWahyu Wulaningsih, Mariam Vahdaninia, Mark Rowley, et al.
Pageof 27